Skip to main content

Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.

Organ sparing approaches for the management of localized prostate cancer were developed in part to overcome the morbidity associated with standard, whole gland treatment options. The first description of focal therapy was now over two decades ago and since that time much has changed. The evolution of patient selection, the approach to ablation, and surveillance after focal therapy have mirrored the technologic advancements in the field as well as the improved understanding of the biology of low-grade, low-risk prostate cancer. This review presents the evidence for the basis of focal therapy from the past to the present and future endeavors.

Division: 
Citation: 

Arcot, Rohith, and Thomas J. Polascik. “Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future. (Accepted)” The Urologic Clinics of North America 49, no. 1 (February 2022): 129–52. https://doi.org/10.1016/j.ucl.2021.07.011.

Published Date: 
Tuesday, February 1, 2022
Published In: 
The Urologic Clinics of North America
PMID: 
34776047